vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study in Patients with Type 1 Diabetes at 55th Annual Meeting of the European Association for the Study of Diabetes September 18, 2019 - NASDAQ Companies 0 » View More News for September 18, 2019